Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioElectronics, a developer of inexpensive, disposable drug-free anti-inflammatory devices, has announced the organization of a new clinical study to demonstrate the efficacy of its Allay menstrual pain therapy product.
Subscribe to our email newsletter
The randomized double-blind, placebo and positive controlled trial involving approximately 120 adult female women began in early March 2009 with data expected in approximately 60 days.
In an initial pilot study, 23 female patients with problematic menstrual issues used the Allay product continuously for five days when the onset of their menstrual period was evident and achieved an overall pain reduction on a daily basis of between 31% and 73%, said BioElectronics.